A rapid methodology for the isolation of intermediate-density lipoprotein: Characterization of lipid composition and apoprotein content

Clinica Chimica Acta

Volumn 353, Issue 1-2, 2005, Pages 117-125

  McFarlane, Cheryl ^a   Young, Ian Stuart ^a   Hare, Leslie ^a   Mahon, Gerry ^b   McEneny, Jane ^a,c  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b ROYAL GROUP OF HOSPITALS   (United Kingdom)

^c Mulhouse Building ^*  (United Kingdom)

Author keywords

Lipid and apoprotein composition; Lipoproteins; Rapid ultracentrifugation

Indexed keywords

APOPROTEIN; INTERMEDIATE DENSITY LIPOPROTEIN;

ARTICLE; AUTOMATION; CONTROLLED STUDY; ELECTROPHORESIS; ENZYME ANALYSIS; EXTRACTION; HUMAN; HUMAN CELL; IMMUNODIFFUSION; LIPID BLOOD LEVEL; LIPID COMPOSITION; PRIORITY JOURNAL; PROTEIN ISOLATION;

EID: 13444280078     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cccn.2004.10.010     Document Type: Article

References (28)

1. H.N. Hodis, W.J. Mack, M. Dunn, C.R. Liu, C.H. Liu, and R.H. Selzer Intermediate-density lipoproteins and progression of carotid arterial wall intima-media thickness Circulation 95 1997 2022 2026
2. G. Steiner, L. Schwartz, S. Shumak, and M. Poapst The association of increased levels of intermediate-density lipoproteins with smoking and with coronary artery disease Circulation 75 1987 124 130
3. R. Tatami, H. Mabuchi, K. Ueda, R. Ueda, T. Haba, and T. Kametani Intermediate-density lipoprotein and cholesterol-rich very low density lipoprotein in angiographically determined coronary artery disease Circulation 64 1981 1174 1184
4. L. Duvillard, F. Pont, E. Florentin, C. Galland-Jos, P. Gambert, and B. Verges Metabolic abnormalities of apolipoprotein B-containing lipoproteins in non-insulin-dependent diabetes: a stable isotope kinetic study Eur. J. Clin. Investig. 30 2000 685 694
5. M.F. Reardon, M.E. Poapst, and G. Steiner The independent synthesis of intermediate density lipoproteins in type III hyperlipoproteinemia Metabolism 31 1982 421 427
6. A.I. Gonzalez, L. Schreier, A. Elbert, G. Berg, H. Beresan, and G. Lopez Lipoprotein alterations in hemodialysis: differences between diabetic and nondiabetic patients Metabolism 52 2003 116 121
7. P.J. Nestel, N.H. Fidge, and M.H. Tan Increased lipoprotein-remnant formation in chronic renal failure N. Engl. J. Med. 307 1982 329 333
8. T. Shoji, Y. Nishizawa, T. Kawagishi, M. Tanaka, K. Kawasaki, and T. Tabata Atherogenic lipoprotein changes in the absence of hyperlipidemia in patients with chronic renal failure treated by hemodialysis Atherosclerosis 131 1997 229 236
9. T. Shoji, Y. Nishizawa, T. Kawagishi, K. Kawasaki, H. Taniwaki, and T. Tabata Intermediate-density lipoprotein as an independent risk factor for aortic atherosclerosis in hemodialysis patients J. Am. Soc. Nephrol. 9 1998 1277 1284
10. N. Harada, A. Kashiwagi, Y. Nishio, and R. Kikkawa Effects of cholesterol-lowering treatments on oxidative modification of plasma intermediate density lipoprotein plus low density lipoprotein fraction in Type 2 diabetic patients Diabetes Res. Clin. Pract. 43 1999 111 120
11. T. Kasama, G. Yoshino, I. Iwatani, M. Iwai, H. Hatanaka, and T. Kazumi Increased cholesterol concentration in intermediate density lipoprotein fraction of normolipidemic non-insulin-dependent diabetics Atherosclerosis 63 1987 263 266
12. G. Steiner Diabetes and atherosclerosis: an overview Diabetes 30 1981 1 7
13. R.M. Krauss, F.T. Lindgren, P.T. Williams, S.F. Kelsey, J. Brensike, and K. Vranizan Intermediate-density lipoproteins and progression of coronary artery disease in hypercholesterolaemic men Lancet 2 1987 62 66
14. N.R. Phillips, D. Waters, and R.J. Havel Plasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical events Circulation 88 1993 2762 2770
15. M.F. Reardon, P.J. Nestel, I.H. Craig, and R.W. Harper Lipoprotein predictors of the severity of coronary artery disease in men and women Circulation 71 1985 881 888
16. W.J. Mack, R.M. Krauss, and H.N. Hodis Lipoprotein subclasses in the Monitored Atherosclerosis Regression Study (MARS). Treatment effects and relation to coronary angiographic progression Arterioscler. Thromb. Vasc. Biol. 16 1996 697 704
17. H.R. Superko What can we learn about dense low density lipoprotein and lipoprotein particles from clinical trials? Curr. Opin. Lipidol. 7 1996 363 368
18. G.L. Mills, P.A. Lane, and P.K. Weech A guidebook to lipoprotein technique 1984 Elsevier Amsterdam
19. R.J. Havel, H.A. Eder, and J.H. Bragdon The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum J. Clin. Invest. 34 1955 1345 1353
20. J. McEneny, C.M. Loughrey, P.T. McNamee, E.R. Trimble, and I.S. Young Susceptibility of VLDL to oxidation in patients on regular haemodialysis Atherosclerosis 129 1997 215 220
21. T.M. Forte, and R.W. Nordhausen Electron microscopy of negatively stained lipoproteins Methods Enzymol. 128 1986 442 457
22. J.S. Cohn, C. Marcoux, and J. Davignon Detection, quantification, and characterization of potentially atherogenic triglyceride-rich remnant lipoproteins Arterioscler. Thromb. Vasc. Biol. 19 1999 2474 2486
23. G.R. Castro, and C.J. Fielding Evidence for the distribution of apolipoprotein E between lipoprotein classes in human normocholesterolemic plasma and for the origin of unassociated apolipoprotein E (Lp-E) J. Lipid Res. 25 1984 58 67
24. J. McEneny, C. McMaster, E.R. Trimble, and I.S. Young Rapid isolation of VLDL subfractions: assessment of composition and susceptibility to copper-mediated oxidation J. Lipid Res. 43 2002 824 831
25. W. Leonhardt, J. Pietzsch, and S. Nitzsche Very-fast ultracentrifugation of human plasma lipoproteins: influence of the centrifugal field on lipoprotein composition Clin. Chim. Acta 224 1994 21 32
26. H. Tong, H.R. Knapp, and M. VanRollins A low temperature flotation method to rapidly isolate lipoproteins from plasma J. Lipid Res. 39 1998 1696 1704
27. C. Lee, F. Sigari, T. Segrado, S. Morkko, S. Hama, and P.V. Subbaiah All ApoB-containing lipoproteins induce monocyte chemotaxis and adhesion when minimally modified. Modulation of lipoprotein bioactivity by platelet-activating factor acetylhydrolase Arterioscler. Thromb. Vasc. Biol. 19 1999 1437 1446
28. Y. Maeno, A. Kashiwagi, Y. Nishio, N. Takahara, and R. Kikkawa IDL can stimulate atherogenic gene expression in cultured human vascular endothelial cells Diabetes Res. Clin. Pract. 48 2000 127 138